Clinical Trial Update: Cannabichromene Safety in Rheumatoid Arthritis [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating the safety of cannabichromene in rheumatoid arthritis has been suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Cannabichromene (cannabichromene)

Snippet

Sponsor: Crystal Lederhos Smith | Conditions: Arthritis, Rheumatoid | Phase 1, Phase 2 | Status: SUSPENDED